Highlights of ASH in North America
Save the Date!
Join the world's leading hematology experts at Highlights of ASH in North America, a two-day program offered in multiple locations that highlights the most influential research presented at the latest ASH annual meeting. Registration opens October 2, 2024!
New York, New York | January 10-11, 2025
Seattle, Washington | January 10-11, 2025
Chicago, Illinois | January 17-18, 2025
Washington D.C. | January 31-February 1, 2025
About Highlights of ASH in North America
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Throughout this meeting, you will be able to:
Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.
Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.
Choose from several dates and locations to best meet your schedule.
Program Schedule
The program schedule below is identical for all 2025 Highlights of ASH in North America locations. The following information is preliminary and subject to change.
| 11:00 a.m. | Registration and Exhibits Open (Lunch provided) | |
| 11:45 p.m. | Welcome and Introductions | |
| 12:00 p.m. | Inherited Disorders of Coagulation | |
| Ayesha Zia, MD University of Texas Southwestern |
Washington, DC | |
| Patrick Ellsworth, MD University of North Carolina |
New York, NY Chicago, IL |
|
| Tyler Buckner, MD, MSc University of Colorado |
Seattle, WA | |
| 12:45 p.m. | Transfusion Medicine | |
| Grace Lee, MD Duke University |
Chicago, IL | |
| Katerina Pavenski, MD, FRCPC University of Toronto |
Seattle, WA Washington, DC |
|
| Michelle Zeller, MD McMaster University |
New York, NY | |
| 1:30 p.m. | Sickle Cell Disease: Disease-Modifying and Curative Therapies | |
| Cecelia Calhoun, MD, MPHS, MBA Yale University |
Seattle, WA Chicago, IL |
|
| Maureen Okam Achebe, MD, MPH Brigham and Women's Hospital |
New York, NY | |
| Rakhi Naik, MD, MHS Johns Hopkins University |
Washington, DC | |
| 2:15 p.m. | Panel Discussion | |
| 2:45 p.m. | Coffee Break and Exhibits Open | |
| 3:00 p.m. | Transplant | |
| Bart L. Scott, MD Fred Hutchinson Cancer Center |
Seattle, WA Washington, DC |
|
| Melody Smith, MD, MS Stanford University |
Chicago, IL | |
| Miguel-Angel Perales, MD Memorial Sloan Kettering Cancer Center |
New York, NY | |
| 3:45 p.m. |
Highlights in Aggressive Lymphoma | |
| Carla Casulo, MD University of Rochester |
Chicago, IL | |
| Manali Kamdar, MD University of Colorado |
Washington, DC | |
| Paul Barr, MD University of Rochester |
Seattle, WA | |
| Sarah Rutherford, MD Weill Cornell Medicine |
New York, NY | |
| 4:30 p.m. | Highlights in Indolent Lymphoma and Chronic Lymphocytic Leukemia | |
| Alexey Danilov, MD, PhD City of Hope National Medical Center |
Seattle, WA | |
| Deborah Stephens, DO University of North Carolina |
Chicago, IL | |
| Jia Ruan, MD, PhD Weill Cornell Medicine |
New York, NY Washington, DC |
|
| 5:30 p.m. | Panel Discussion | |
| 6:00 p.m. |
Program Adjourns for the day Satellite Symposia |
|
| 7:00 a.m. | Registration and Exhibits Open (Breakfast provided) |
|
| 7:45 a.m. | Welcome, Introductions, and Announcements | |
| 8:00 a.m. |
Intersection of Women’s Health and Hematology |
|
| Bethany Samuelson Bannow, MD Oregon Health and Science University Medicine |
Seattle, WA | |
| Menaka Pai, MD FRCPC McMaster University |
Chicago, IL | |
| Sarah H. O'Brien, MD, MSc Nationwide Children's |
New York, NY Washington, DC |
|
| 8:45 a.m. |
Clinical Applications of Health Outcomes Research for Blood Cancers |
|
| Areej El-Jawahri, MD Massachusetts General Hospital |
Seattle, WA | |
| Pamela Egan, MD Maine Health |
Washington, DC | |
| Thomas W. LeBlanc, MD, MS, MA Duke University |
New York, NY Chicago, IL |
|
| 9:30 a.m. |
Consultative Hematology |
|
| Cyrus Hsia, MD, FRCPC Western University |
New York, NY | |
| Jacquelyn M. Powers, MD Texas Children’s Hospital |
Chicago, IL | |
| Joseph Shatzel, MD Oregon Health and Science University Medicine |
Seattle, WA Washington, DC |
|
| 10:15 a.m. | Panel Discussion | |
| 10:45 a.m. | Coffee Break and Exhibits Open | |
| 11:00 a.m. |
Myelodysplastic Syndromes and Clonal Hematopoiesis |
|
| Afaf Osman, MD University of Utah |
Seattle, WA | |
| Guillermo Garcia-Manero, MD Anderson Cancer Center |
Chicago, IL | |
| Morgan Jones, MD, PhD University of Michigan |
New York, NY Washington, DC |
|
| 11:45 a.m. |
Myeloproliferative Neoplasms including Chronic Myeloid Leukemia |
|
| Andrew Kuykendall, MD Moffitt Cancer Center |
Seattle, WA | |
| Chi-Joan How, MD Brigham and Women’s Hospital |
Washington, DC | |
| Douglas Tremblay, MD Mount Sinai |
New York, NY | |
| Kristen Pettit, MD University of Michigan |
Chicago, IL | |
| 12:30 p.m. | Panel Discussion | |
| 1:00 p.m. | Lunch with the Experts (All Speakers and Attendees) |
|
| 2:15 p.m. |
Acute Lymphoblastic Leukemia |
|
| Adam Duvall, MD University of Chicago |
Chicago, IL | |
| Patrick Burke, MD University of Michigan |
Seattle, WA | |
| Ryan Mattison, MD University of Wisconsin |
New York, NY Washington, DC |
|
| 3:00 p.m. |
Myeloma, MGUS, and Plasma Cell Disorders |
|
| Doris Hansen, MD Moffitt Cancer Center |
Chicago, IL | |
| Jonathan Kaufman, MD Emory University |
Seattle, WA Washington, DC |
|
| Susan Bal, MD University of Alabama at Birmingham |
New York, NY | |
| 3:45 p.m. |
Acute Myeloid Leukemia |
|
| Catherine Lai, MD, MPH University of Pennsylvania |
Seattle, WA | |
| Charles Foucar, MD University of New Mexico |
Chicago, IL | |
| Courtney DiNardo, MD MD Anderson Cancer Center |
Washington, DC | |
| Jerald Radich, MD Fred Hutchinson Cancer Center |
New York, NY | |
| 4:30 p.m. | Panel Discussion | |
| 5:00 p.m. | Closing Remarks and Adjournment | |
Acknowledgements
Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, and our company partners for providing educational grants in support of the 2025 Highlights of ASH in North America
- Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine
- Tyler Buckner, MD, MSc, University of Colorado Denver
- Pamela Egan, MD, Maine Health
- Manali Kamdar, MD, University of Colorado
- Jonathan L. Kaufman, MD, Emory University
- Rakhi Naik, MD, MHS, Johns Hopkins University
- Kristen Pettit, MD, University of Michigan
- Eric Tse, PhD, MBBS, Hong Kong University
- Michelle Zeller, MD, McMaster University
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission